The Lugano classification is the lymphoma staging system: stage I to IV by how many lymph node regions and organs are involved, with PET-based response criteria.
The Lugano classification is the staging and response system for lymphoma: stages I to IV are assigned by how many lymph node regions and organs are involved, and response is judged on FDG PET-CT using the Deauville five-point scale. Published in 2014, it merged the older Ann Arbor staging with PET-based response assessment and dropped the bulky-disease and X designations in favour of measured diameters. Readers meet it on the pages for diffuse large B-cell lymphoma, Hodgkin lymphoma, follicular lymphoma, mantle cell lymphoma and the peripheral T-cell lymphomas, since it is common to all of them. It is the framework within which FDG PET, the linked technology, is read in lymphoma.
Showing the technology this term belongs to: FDG PET.
Shares IELSG37, Mediastinal grey zone lymphoma, FDG PET, Early-stage classical Hodgkin lymphoma (stage I to II).
Shares Mediastinal grey zone lymphoma, Primary cutaneous anaplastic large cell lymphoma, ALK-positive anaplastic large cell lymphoma, Primary large B-cell lymphoma of the testis.
Shares IELSG37, Radiotherapy in lymphoma: involved-site fields, 24 Gy, 4 Gy and total skin electron therapy, FDG PET, Early-stage classical Hodgkin lymphoma (stage I to II).
Shares FLIPI, FLIPI2 and POD24 (follicular lymphoma risk), Radiotherapy in lymphoma: involved-site fields, 24 Gy, 4 Gy and total skin electron therapy, FDG PET, Early-stage classical Hodgkin lymphoma (stage I to II).
Shares Mediastinal grey zone lymphoma, ALK-positive anaplastic large cell lymphoma, Adult T-cell leukaemia/lymphoma, Extranodal NK/T-cell lymphoma.
Shares Nodular lymphocyte-predominant Hodgkin lymphoma (nodular lymphocyte-predominant B-cell lymphoma), Early-stage classical Hodgkin lymphoma (stage I to II), Advanced-stage classical Hodgkin lymphoma (stage III to IV), Primary mediastinal (thymic) large B-cell lymphoma.
Shares ALK-positive anaplastic large cell lymphoma, Adult T-cell leukaemia/lymphoma, FLIPI, FLIPI2 and POD24 (follicular lymphoma risk), Extranodal NK/T-cell lymphoma.
Shares Early-stage classical Hodgkin lymphoma (stage I to II), Advanced-stage classical Hodgkin lymphoma (stage III to IV), Primary mediastinal (thymic) large B-cell lymphoma, Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma).